In a testament to the deepening ties between India and Bangladesh, a new milestone was marked as Sun Pharma, a leading Indian pharmaceutical company, inaugurated its latest plant in Bangladesh.

The inauguration ceremony, graced by Private Industry and Investment Adviser of Bangladesh Prime Minister Salman F Rahman and Indian High Commissioner to Bangladesh Pranay Verma, underscored the significance of bilateral collaboration in driving the growth trajectory of the pharmaceutical industry in both nations.

Situated at the Meghna Industrial Economic Zone in the Sonargaon upazila of Narayanganj district, adjacent to the Dhaka-Chittagong highway, the new plant represents Sun Pharma's second investment in Bangladesh. With a production capacity exceeding 1 billion tablets and capsules per year, Sun Pharma aims to bolster its presence in the country and contribute to the healthcare landscape of Bangladesh.

Pranay Verma, the Indian High Commissioner to Bangladesh, hailed the inauguration as a testament to the expanding economic and industrial partnership between India and Bangladesh. He emphasized India's role as a reliable partner in Bangladesh's pharmaceutical journey, catering to approximately 30 percent of the country's Active Pharmaceutical Ingredients (API) demand.

Highlighting the significance of the new plant, Verma underscored India's enduring commitment to fostering collaborative ties with Bangladesh, reflecting the growing interest among Indian businesses to invest in the burgeoning economy.

The High Commissioner lauded the robust bilateral cooperation in the health sector, citing India's support to Bangladesh during the COVID-19 pandemic through initiatives like 'Vaccine Maitri' and the supply of critical medicines. He noted Bangladesh's strides in the pharmaceutical domain, positioning the country as a key player in generic drug manufacturing.

With Bangladesh's renewed focus on domestic production and government incentives, Verma emphasized the ample opportunities for Indian manufacturers to forge partnerships with Bangladeshi companies through Joint Ventures, joint R&D efforts, and technology tie-ups.

The inauguration of Sun Pharma's new plant signifies a significant milestone in the bilateral relationship between India and Bangladesh, underlining the shared commitment to fostering economic growth and enhancing healthcare accessibility. As both nations continue to strengthen their partnership across various sectors, the pharmaceutical industry stands as a shining example of collaborative success and mutual benefit.